US Patent

US10166205 — Topical compositions and methods for making and using same

Formulation · Assigned to Sebela International Bermuda Ltd · Expires 2033-01-31 · 7y remaining

Vulnerability score 42/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a gel composition for topical administration that includes naftifine or a pharmaceutically acceptable salt thereof.

USPTO Abstract

A gel composition for topical administration that includes: naftifine or a pharmaceutically acceptable salt thereof; a solvent; a non-carbomer rheology modifier; a polysorbate solubilizing agent; and an amine pH adjuster.

Drugs covered by this patent

naftifine-hydrochloride (NAFTIFINE HYDROCHLORIDE)

Patent Metadata

Patent number: US10166205
Jurisdiction: US
Classification: Formulation
Expires: 2033-01-31
Drug substance claim: No
Drug product claim: Yes
Assignee: Sebela International Bermuda Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.